Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

The Centers for Medicare and Medicaid Services (CMS) is launching a pilot program on July 1 to subsidize costs of GLP-1s ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

A new CMS pilot gives seniors $50 access to GLP-1 drugs like Wegovy, potentially reshaping food demand, nutrition strategies ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

On June 16, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule, “Medicare Drug Price Negotiation Program and ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The ...

The Centers for Medicare and Medicaid Services has signaled plans to make cuts to the Medicaid program, saying it wants to put an end to "mounting expenditures," such as housekeeping for ...